Novo’s Wegovy pill hits over 18,000 US prescriptions in strong debut week – One America News Network

0
95

By Sriparna Roy
January 23, 2026 – 8:14 AM PST

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Denmark, December 3, 2025. REUTERS/Tom Little/File Photo

(Reuters) – Novo Nordisk’s (NOVOb.CO) Wegovy ​pill was prescribed more than 18,000 times in the U.S. in the first full week after ‌its launch in an encouraging start to the oral weight-loss drug race, according to analysts who cited IQVIA data.

Investors are closely watching prescriptions data to see if the Danish drugmaker can press its first-mover advantage against rival Eli Lilly (LLY.N) in a competitive weight-loss market.

Oral obesity treatments offer patients greater flexibility and a needle-free alternative, although injectable medications are still ‌expected to dominate for years to come.

At least two analysts…

Read more…

LEAVE A REPLY

Please enter your comment!
Please enter your name here